T Cell-Mediated Targeted Delivery of Anti-PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site.

Petit PF, Bombart R, Desimpel PH, Naulaerts S, Thouvenel L, Collet JF, Van den Eynde BJ, Zhu J
Cancer Immunol Res. 2022 Jun 3;10(6):713-727. doi: 10.1158/2326-6066.CIR-21-0801. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.